NCT06969378Withdrawn
Empiric Pulsed Field Pulmonary Vein Isolation During Atrial Tachycardia Ablation in Adults With Congenital Heart Disease
Source: ClinicalTrials.gov · Last updated 14 Jul 2026
Reason given: Never started
Brief summary (registry, in English)
This is a prospective, single-arm intervention trial whereby we will test the safety and efficacy of performing pulmonary vein isolation (PVI) using pulsed field ablation (PFA) in adult patients with congenital heart disease (CHD) who are presenting for atrial tachycardia (AT) ablation.
- Status (registry)
- Withdrawn
- Study type
- Interventional
- Enrollment
- 0 (actual)
- First submitted
- 5 May 2025
- Start date
- 1 Jul 2025
- Primary completion date
- 30 Jun 2026
- Lead sponsor
- Boston Children's Hospital
- Diseases
- Atrial fibrillation
- NCT number
- NCT06969378
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- History of sustained AF and/or previous catheter or surgical pulmonary vein isolation.
Who the study is looking for
- Adult patients (>= 18 years of age) with repaired or unrepaired congenital heart disease and a history of sustained (>30 seconds) AT
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.